Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22823753 | 1.00 | PTGDR2 (0.33) | PTGDR2AAK1CYP3A4TSHRKMT2A | |
| SCHEMBL29602355 | 0.87 | HMGCR (0.35) | AAK1 | |
| SCHEMBL22823745 | 0.87 | HMGCR (0.35) | AAK1 | |
| SCHEMBL28676314 | 0.87 | HMGCR (0.35) | AAK1 | |
| SCHEMBL22823752 | 0.86 | PTGDR2 (0.32) | PTGDR2AAK1CYP3A4TSHR | |
| SCHEMBL29602017 | 0.86 | PTGDR2 (0.32) | PTGDR2AAK1CYP3A4TSHR | |
| SCHEMBL29369380 | 0.86 | PTGDR2 (0.32) | PTGDR2AAK1CYP3A4TSHR | |
| SCHEMBL31324223 | 0.85 | PTGDR2 (0.36) | PTGDR2AAK1CYP3A4TSHR | |
| SCHEMBL22824021 | 0.80 | PTGDR2 (0.52) | PTGDR2CYP3A4KMT2AHTT | |
| SCHEMBL29602362 | 0.80 | PTGDR2 (0.52) | PTGDR2CYP3A4KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114008012-B | Compounds for the treatment of neuromuscular disorders | NMD制药股份公司 | 2025-02-25 | — | — | CN | disclosed |
| EP-3986852-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2022-04-27 | — | — | EP | disclosed |